Matches in SemOpenAlex for { <https://semopenalex.org/work/W4291173185> ?p ?o ?g. }
- W4291173185 endingPage "855" @default.
- W4291173185 startingPage "845" @default.
- W4291173185 abstract "Abstract Despite the effectiveness of immuno-chemotherapy, 40% of patients with diffuse large B-cell lymphoma (DLBCL) experience relapse or refractory disease. Longitudinal studies have previously focused on the mutational landscape of relapse but fell short of providing a consistent relapse-specific genetic signature. In our study, we have focused attention on the changes in GEP accompanying DLBCL relapse using archival paired diagnostic/relapse specimens from 38 de novo patients with DLBCL. COO remained stable from diagnosis to relapse in 80% of patients, with only a single patient showing COO switching from activated B-cell–like (ABC) to germinal center B-cell–like (GCB). Analysis of the transcriptomic changes that occur following relapse suggest ABC and GCB relapses are mediated via different mechanisms. We developed a 30-gene discriminator for ABC–DLBCLs derived from relapse-associated genes that defined clinically distinct high- and low-risk subgroups in ABC–DLBCLs at diagnosis in datasets comprising both population-based and clinical trial cohorts. This signature also identified a population of <60-year–old patients with superior PFS and OS treated with ibrutinib–R-CHOP as part of the PHOENIX trial. Altogether this new signature adds to the existing toolkit of putative genetic predictors now available in DLBCL that can be readily assessed as part of prospective clinical trials." @default.
- W4291173185 created "2022-08-13" @default.
- W4291173185 creator A5007119947 @default.
- W4291173185 creator A5014743270 @default.
- W4291173185 creator A5015977621 @default.
- W4291173185 creator A5016018407 @default.
- W4291173185 creator A5020958843 @default.
- W4291173185 creator A5021133318 @default.
- W4291173185 creator A5024619109 @default.
- W4291173185 creator A5032833705 @default.
- W4291173185 creator A5033435736 @default.
- W4291173185 creator A5042174545 @default.
- W4291173185 creator A5043066957 @default.
- W4291173185 creator A5044305977 @default.
- W4291173185 creator A5046387225 @default.
- W4291173185 creator A5047655557 @default.
- W4291173185 creator A5047711932 @default.
- W4291173185 creator A5052226048 @default.
- W4291173185 creator A5055238920 @default.
- W4291173185 creator A5055535893 @default.
- W4291173185 creator A5055598550 @default.
- W4291173185 creator A5057108515 @default.
- W4291173185 creator A5057293622 @default.
- W4291173185 creator A5059022907 @default.
- W4291173185 creator A5063080149 @default.
- W4291173185 creator A5063787927 @default.
- W4291173185 creator A5064643006 @default.
- W4291173185 creator A5067141162 @default.
- W4291173185 creator A5067154165 @default.
- W4291173185 creator A5067695671 @default.
- W4291173185 creator A5068165606 @default.
- W4291173185 creator A5069477380 @default.
- W4291173185 creator A5069863753 @default.
- W4291173185 creator A5076086549 @default.
- W4291173185 creator A5079048180 @default.
- W4291173185 creator A5082370164 @default.
- W4291173185 creator A5089462093 @default.
- W4291173185 creator A5090807802 @default.
- W4291173185 date "2023-03-06" @default.
- W4291173185 modified "2023-09-28" @default.
- W4291173185 title "Longitudinal expression profiling identifies a poor risk subset of patients with ABC-type diffuse large B-cell lymphoma" @default.
- W4291173185 cites W1985987855 @default.
- W4291173185 cites W2022397091 @default.
- W4291173185 cites W2029192827 @default.
- W4291173185 cites W2037796411 @default.
- W4291173185 cites W2058015212 @default.
- W4291173185 cites W2058574523 @default.
- W4291173185 cites W2076408955 @default.
- W4291173185 cites W2130410032 @default.
- W4291173185 cites W2136268782 @default.
- W4291173185 cites W2138550913 @default.
- W4291173185 cites W2178959886 @default.
- W4291173185 cites W2193707124 @default.
- W4291173185 cites W2406971307 @default.
- W4291173185 cites W2414958612 @default.
- W4291173185 cites W2626615329 @default.
- W4291173185 cites W2762450632 @default.
- W4291173185 cites W2788847923 @default.
- W4291173185 cites W2794197897 @default.
- W4291173185 cites W2796143133 @default.
- W4291173185 cites W2797584152 @default.
- W4291173185 cites W2801763724 @default.
- W4291173185 cites W2806493073 @default.
- W4291173185 cites W2900881192 @default.
- W4291173185 cites W2902375153 @default.
- W4291173185 cites W2903278833 @default.
- W4291173185 cites W2921072067 @default.
- W4291173185 cites W2923453543 @default.
- W4291173185 cites W2928384177 @default.
- W4291173185 cites W2973536206 @default.
- W4291173185 cites W2973607898 @default.
- W4291173185 cites W2980823426 @default.
- W4291173185 cites W2981973487 @default.
- W4291173185 cites W2994898326 @default.
- W4291173185 cites W3012464003 @default.
- W4291173185 cites W3015964023 @default.
- W4291173185 cites W3016044607 @default.
- W4291173185 cites W3037474453 @default.
- W4291173185 cites W3091408048 @default.
- W4291173185 cites W3119448891 @default.
- W4291173185 cites W3128501672 @default.
- W4291173185 cites W3132205831 @default.
- W4291173185 cites W3209622492 @default.
- W4291173185 doi "https://doi.org/10.1182/bloodadvances.2022007536" @default.
- W4291173185 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35947123" @default.
- W4291173185 hasPublicationYear "2023" @default.
- W4291173185 type Work @default.
- W4291173185 citedByCount "0" @default.
- W4291173185 crossrefType "journal-article" @default.
- W4291173185 hasAuthorship W4291173185A5007119947 @default.
- W4291173185 hasAuthorship W4291173185A5014743270 @default.
- W4291173185 hasAuthorship W4291173185A5015977621 @default.
- W4291173185 hasAuthorship W4291173185A5016018407 @default.
- W4291173185 hasAuthorship W4291173185A5020958843 @default.
- W4291173185 hasAuthorship W4291173185A5021133318 @default.
- W4291173185 hasAuthorship W4291173185A5024619109 @default.
- W4291173185 hasAuthorship W4291173185A5032833705 @default.
- W4291173185 hasAuthorship W4291173185A5033435736 @default.